| Mitogens |
Kv1.3 blockers (Concentration) |
Viability (%) |
|
| Control |
Stress |
||
| None |
None |
91.3 ± 2.1 |
96.9 ± 0.6 |
| Con A |
None |
94.8 ± 0.3 |
83.2 ± 0.5 |
| Quinine (4.0 × 10−5 M) |
90.3 ± 1.4 |
87.3 ± 3.4 |
|
| 4-AP (4.0 × 10−3 M) |
90.8 ± 0.0 |
87.2 ± 1.7 |
|
| TEA (1.0 × 10−2 M) |
94.3 ± 0.6 |
85.4 ± 1.3 |
|
| TMA (4.0 × 10−2 M) |
93.2 ± 1.1 |
83.5 ± 2.6 |
|
| LPS |
None |
83.4 ± 1.3 |
89.4 ± 2.0 |
| Quinine (4.0 × 10−5 M) |
92.8 ± 1.4 |
83.8 ± 0.9 |
|
| 4-AP (4.0 × 10−3 M) |
94.0 ± 1.8 |
84.8 ± 1.3 |
|
| TEA (1.6 × 10−2 M) |
91.2 ± 2.0 |
84.0 ± 1.0 |
|
| TMA (1.6 × 10−2 M) |
92.3 ± 1.5 |
87.7 ± 1.3 |
|